AT₁ angiotensin II receptor and novel non-AT₁, non-AT₂ angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat.
Spontaneously hypertensive rats (SHR) have an activated brain angiotensin system that contributes to the elevation of blood pressure in this animal model. Physiological and pharmacological studies suggest that hyperactivation of brain AT₁ angiotensin receptors is a major pathophysiological factor. Consistent with these observations, radioligand binding studies indicate widespread up-regulation of brain angiotensin receptors in SHR. One key brainstem site in which AT₁ receptor stimulation appears to contribute to the elevated blood pressure in SHR is the rostral ventrolateral medulla (RVLM). However, no quantitative comparison of AT₁ receptor binding in the RVLM has been made in SHR versus normotensive rats. A novel, non-AT₁, non-AT₂ binding site, specific for angiotensins II and III, has recently been discovered in the brain. To determine if radioligand binding to either AT₁ receptors or this novel angiotensin binding site is altered in the RVLM and other caudal brainstem regions of SHR, a quantitative densitometric autoradiographic comparison of radioligand binding in SHR versus normotensive Wistar-Kyoto rats was made. In both the RVLM and caudal ventrolateral medulla (CVLM) as well as dorsomedial medulla (DMM), there was increased expression of AT₁ receptor binding in SHR (13%, 9%, and 23%, respectively). Conversely, expression of the novel, non-AT₁, non-AT₂, angiotensin II and III binding site was decreased in the RVLM and DMM of SHR (37% and 13%, respectively). This increased AT₁ receptor binding in the RVLM may contribute to the hypertension of SHR. Reduced radioligand binding to the novel, non-AT₁, non-AT₂, angiotensin binding site in the RVLM of SHR may indicate a role for this binding site to reduce blood pressure via its interactions with angiotensins II and III.
Bourassa
Erick A
EA
Biological Sciences, Northwest Missouri State University, Maryville, MO 64468, USA.
Fang
Xiefan
X
Li
Xia
X
Sved
Alan F
AF
Speth
Robert C
RC
D000818:Animals; D001345:Autoradiography; D007091:Image Processing, Computer-Assisted; D008297:Male; D011869:Radioligand Assay; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*; D012125:Respiratory Center / Q000378:metabolism*
D044140:Receptor, Angiotensin, Type 1
Hypertension. 2002 Oct;40(4):552-9
12364362
Pharmacol Ther. 2008 Dec;120(3):292-316
18804122
Brain Res. 2010 Jan 8;1306:69-76
19835848
Am J Physiol. 1996 Jun;270(6 Pt 2):R1317-23
8764299
Methods Mol Med. 2001;51:275-95
21331724
Physiol Genomics. 2004 Nov 17;19(3):255-61
15383639
Regul Pept. 2010 Jun 8;162(1-3):5-11
20171994
Eur J Pharmacol. 2008 Aug 20;590(1-3):87-92
18571643
Clin Exp Pharmacol Physiol. 1993 May;20(5):351-4
8100748
Peptides. 1986 Nov-Dec;7(6):1021-7
3562315
Clin Exp Pharmacol Physiol. 2002 Jan-Feb;29(1-2):103-11
11906467
Int Rev Exp Pathol. 1969;7:227-70
4387955
Brain Res. 1997 Oct 24;772(1-2):107-14
9406962
Hypertension. 1980 Jul-Aug;2(4):546-50
6995295
Neuroendocrinology. 2008;88(4):256-65
18562784
Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2961-6
11087253
Curr Hypertens Rep. 2003 Jun;5(3):262-8
12724060
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):283-93
18172611
Brain Res. 2007 Apr 27;1143:83-91
17306233
Hypertension. 1992 May;19(5):475-81
1568766
J Mol Cell Cardiol. 1996 Feb;28(2):351-61
8729067
Brain Res. 2005 Mar 2;1036(1-2):70-6
15725403
Nature. 1977 Dec 1;270(5636):445-7
593364
J Hypertens. 1988 Jan;6(1):79-84
3351297
Nat Rev Neurosci. 2006 May;7(5):335-46
16760914
Nature. 1975 Nov 20;258(5532):267-8
1202361
Am J Physiol. 1984 Sep;247(3 Pt 2):R575-81
6089597
J Mol Med (Berl). 2008 Jun;86(6):715-22
18385968
Endocrine. 2010 Jun;37(3):442-8
20960166
J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1_suppl):S120-S124
28095229
Blood Press Suppl. 1994;5:21-6
7889197
Am J Physiol. 1991 May;260(5 Pt 2):R977-84
1674644
Pharmacology. 2007;80(2-3):166-76
17551266
Hypertension. 2010 Feb;55(2):207-13
20038757
Life Sci. 2008 Sep 12;83(11-12):421-5
18692076
Hypertension. 2006 Jun;47(6):1054-61
16618838
Am J Physiol. 1986 Feb;250(2 Pt 2):R193-8
3946636
Clin Exp Pharmacol Physiol. 2006 Aug;33(8):690-5
16895541
J Hypertens. 2007 Nov;25(11):2334-44
17921830
Br J Pharmacol. 2003 May;139(2):191-202
12770924
Brain Res Bull. 1998 Sep 1;47(1):17-28
9766385
Brain Res Bull. 2003 May 15;60(3):209-14
12754082
Am J Physiol Regul Integr Comp Physiol. 2006 Apr;290(4):R1027-34
16306161
Am J Physiol. 1994 Jul;267(1 Pt 2):H259-66
7914065
Am J Physiol. 1999 Sep;277(3):R904-9
10484510
Jpn Circ J. 1963 Mar;27:282-93
13939773
J Appl Physiol (1985). 2002 May;92(5):2153-61
11960969
Mol Cell Endocrinol. 2009 Apr 29;302(2):167-75
19027823
Dev Psychobiol. 1991 Nov;24(7):507-19
1797594